
The aim of this study was to evaluate feasibility and toxicity of zzso zzso a zzso zzso directed against the vascular zzso growth factor in children and young zzso 

Fifteen patients zzso zzso zzso zzso female: zzso zzso 7; median age, zzso zzso received zzso for zzso or progressive solid tumors zzso zzso zzso 3; zzso zzso zzso 2; zzso grade zzso zzso zzso 2; zzso zzso zzso 2; zzso zzso zzso 2; benign vascular zzso zzso zzso 2; zzso zzso zzso zzso 1; and zzso zzso zzso zzso 1) on a compassionate zzso zzso was administered at zzso zzso body weight zzso every 2-3 zzso Most patients received chemotherapy in addition to zzso zzso of zzso therapy ranged from zzso to 23 zzso 

zzso zzso were mild and included zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso local zzso zzso zzso 1), and defective wound healing and zzso zzso zzso zzso zzso objective responses zzso zzso were observed in two patients with zzso grade III and in one patient each with zzso and zzso zzso zzso 

zzso seems to have a good acute safety profile and some zzso activity in heavily zzso children and young adults with zzso solid zzso Prospective clinical trials are urgently needed to further evaluate the safety and efficacy of zzso in pediatric zzso 

